IRIDEX Corporation (IRIX)
NASDAQ: IRIX · Real-Time Price · USD
1.280
+0.040 (3.23%)
At close: Mar 9, 2026, 4:00 PM EDT
1.310
+0.030 (2.34%)
After-hours: Mar 9, 2026, 6:50 PM EDT
IRIDEX Revenue
IRIDEX had revenue of $12.48M in the quarter ending September 27, 2025, with 7.80% growth. This brings the company's revenue in the last twelve months to $50.65M, up 4.58% year-over-year. In the year 2024, IRIDEX had annual revenue of $48.67M, down -6.17%.
Revenue (ttm)
$50.65M
Revenue Growth
+4.58%
P/S Ratio
0.43
Revenue / Employee
$544,591
Employees
93
Market Cap
22.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 48.67M | -3.20M | -6.17% |
| Dec 30, 2023 | 51.87M | -5.10M | -8.96% |
| Dec 31, 2022 | 56.97M | 3.07M | 5.69% |
| Jan 1, 2022 | 53.90M | 17.56M | 48.30% |
| Jan 2, 2021 | 36.35M | -7.10M | -16.34% |
| Dec 28, 2019 | Pro | Pro | Pro |
| Dec 29, 2018 | Pro | Pro | Pro |
| Dec 30, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Jan 2, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nortech Systems | 116.67M |
| Trinity Biotech | 48.57M |
| Myomo | 41.64M |
| Vivos Therapeutics | 17.32M |
| Pulsenmore | 2.76M |
| VolitionRx | 1.47M |
| Movano | 500.00K |
| Adagio Medical Holdings | 137.00K |
IRIX News
- 5 weeks ago - Iridex Announces Plans to Relocate Headquarters - GlobeNewsWire
- 2 months ago - Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025 - GlobeNewsWire
- 3 months ago - Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management - GlobeNewsWire
- 3 months ago - Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment - GlobeNewsWire
- 3 months ago - Iridex to Present at the Sidoti Year-End Virtual Investor Conference - GlobeNewsWire
- 4 months ago - IRIDEX Corporation (IRIX) Q3 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha
- 4 months ago - Iridex Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025 - GlobeNewsWire